Careers

May 28, 2021 Putting People First Has Never Been More Important Kasha Witkos, SVP Head of CEMEA Region at Alnylam discusses Alnylam's offices in UK, Switzerland and Germany being named Best Workplaces by Great Place to Work Read More ›
February 6, 2021 Alnylam Named to Bloomberg's 2021 Gender-Equality Index Alnylam has been selected to Bloomberg's Gender-Equality Index for 2021 Read More ›
November 20, 2020 6 in a Row! Alnylam Named a Boston Globe Top Place to Work for 2020 Alnylam has been named to The Boston Globe's Top Places to Work list for 2020, marking 6th years in a row. Read More ›
May 12, 2020 Alnylam Named a Great Place to Work in the UK and Switzerland for Second Year in a Row Alnylam has recognized for the second year in a row as a Best Workplace 2020 in the UK and in Switzerland Read More ›
November 18, 2019 Alnylam Named a Boston Globe Top Place to Work for 5th Year in a Row We're thrilled to be named a Top Places to Work for 2019 by The Boston Globe in the "Large Employer" category, marking our fifth year in a row on the list.  Read More ›
October 25, 2019 Alnylam Named #1 Biopharma Employer by Science Magazine Alnylam has been named the #1 science employer in biopharma for 2019 by Science Magazine and Science Careers. This is our first appearance on the list. Read More ›
June 10, 2019 Alnylam Named a Best Workplace in Switzerland & UK Alnylam's offices in Maidenhead, UK and Zug, Switzerland were both recently named to Great Place to Work's Best Workplaces for 2019. Read More ›
November 16, 2018 Alnylam Named a Boston Globe Top Place to Work for the 4th Year in a Row Alnylam has been named to the Boston Globe's list of Top Places to Work for 2018 marking our fourth year in a row on the list.  We are ranked #18 out of the... Read More ›
November 8, 2018 Celebrating Alnylam's 1000th Employee! We were founded 16 years ago on the belief that we could translate the Nobel Prize-winning discovery of RNA interference (#RNAi) into an entirely new class... Read More ›

Get In Touch

Have any questions or comments about the content you see on this page?

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site